CASP3 and diabetic encephalopathy: Moreover, as suggested by low expressions of TNF-α, iba1, Fas, and caspase 3 in brain tissue, treatment with F5 also prevented neuroinflammation and neuronal loss, which are key mechanistic features of diabetic encephalopathy [15, 24, 25, 48].